Fnx Performance products are intended strictly for qualified in vitro laboratory research. For Research Use Only. Not for human or animal consumption. Not for compounding or therapeutic application.
Epitalon, Telomerase activating tetrapeptide
A synthetic tetrapeptide (Ala-Glu-Asp-Gly) analog of the pineal peptide epithalamin, studied for telomerase activation and pineal/melatonin rhythm regulation in aging models.

A four amino acid pineal peptide studied for switching telomerase back on in human cells, the basis for its telomere and longevity research.
Telomere elongation
Aging biology
Pineal regulation
Bars indicate how far the evidence has progressed (in vitro to animal to human), not the size of any effect.
Khavinson VK, Bondarev IE, Butyugov AA
In telomerase negative human fibroblasts, Epithalon induced hTERT expression, telomerase activity, and telomere elongation.
In vitro it activated telomerase and extended human fibroblast proliferation past the Hayflick limit; animal studies report ~13% lifespan extension in rats and reduced spontaneous tumors. The literature is dominated by a single group (Khavinson, St. Petersburg) with limited independent replication; no modern, independent RCT confirms anti aging benefit in humans.
Telomerase activation is double edged, the same mechanism is exploited by most cancers, so theoretical oncogenic risk is real if it genuinely activates telomerase systemically. Long term human safety unknown.
Active/history of malignancy (theoretical); pregnancy.
Approved for human use in Russia; not FDA approved. Category 2 (2023), removed April 2026 (grey zone); PCAC review July 24, 2026 (insomnia). WADA: would fall under S0.
Source: Fnx Performance Peptide Research Database, a synthesis of the scientific and regulatory literature, not medical advice. For medical questions, consult a qualified physician.